R1 RCM Inc. (RCM)
NASDAQ: RCM · Real-Time Price · USD
14.18
-0.01 (-0.07%)
Oct 3, 2024, 4:00 PM EDT - Market closed
R1 RCM Revenue
R1 RCM had revenue of $627.90M in the quarter ending June 30, 2024, with 11.99% growth. This brings the company's revenue in the last twelve months to $2.38B, up 11.46% year-over-year. In the year 2023, R1 RCM had annual revenue of $2.25B with 24.79% growth.
Revenue (ttm)
$2.38B
Revenue Growth
+11.46%
P/S Ratio
2.50
Revenue / Employee
$79,323
Employees
30,000
Market Cap
5.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.25B | 447.80M | 24.79% |
| Dec 31, 2022 | 1.81B | 331.80M | 22.50% |
| Dec 31, 2021 | 1.47B | 204.50M | 16.10% |
| Dec 31, 2020 | 1.27B | 84.00M | 7.08% |
| Dec 31, 2019 | 1.19B | 317.60M | 36.57% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jazz Pharmaceuticals | 3.91B |
| PACS Group | 3.56B |
| Acadia Healthcare Company | 3.06B |
| Merit Medical Systems | 1.30B |
| Stevanato Group | 1.17B |
| Ionis Pharmaceuticals | 813.46M |
| Inspire Medical Systems | 705.71M |
| Blueprint Medicines | 362.80M |
RCM News
- 6 weeks ago - R1 RCM Stock - Investigation Regarding the Fairness and Adequacy of the Sale of R1 RCM Inc. - Contact Kehoe Law Firm, P.C. For Details - RCM - Accesswire
- 7 weeks ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCM, ESGR on Behalf of Shareholders - GlobeNewsWire
- 2 months ago - R1 RCM Inc. (RCM) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - R1 RCM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of R1 RCM Inc. - RCM - Business Wire
- 2 months ago - R1 RCM to be taken over for $8.9 billion - Market Watch
- 2 months ago - R1 RCM to be Acquired by TowerBrook and CD&R for $8.9 Billion - GlobeNewsWire
- 2 months ago - RCM STOCKHOLDER NOTICE: R1 RCM Inc. (Nasdaq:RCM) Shareholders are Alerted that BFA Law is Investigating the Upcoming Merger and are Notified to Contact the Firm - Accesswire
- 2 months ago - R1 RCM Inc. Shareholders are Notified that an Investigation has been Initiated into the Acquisition Price; Contact BFA Law for Information - Accesswire